Obligacje
Poniżej znajduje się lista obligacji korporacyjnych AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
|---|---|---|---|---|---|---|---|---|---|
| AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7,00% | 26 K | 76,04% | 4,750% | 2045-03-15 | 53,51 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
| AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 6,53% | 24 K | 82,04% | 4,850% | 2044-06-15 | 65,23 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
| AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 6,50% | 135 K | 80,85% | 4,625% | 2042-10-01 | 67,49 M USD | 1 000,00 USD | 2 000,00 USD | Actavis, Inc. |
| 5,54% | 0 | 92,03% | 2,625% | 2028-11-15 | 72,11 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS | |
| 5,49% | 26 K | 90,47% | 3,200% | 2029-11-21 | 62,52 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,34% | 2,21 M | 102,55% | 5,500% | 2064-03-15 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 5,30% | 22 K | 94,50% | 4,550% | 2035-03-15 | 107,65 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
| 5,26% | 10,03 M | 105,03% | 5,600% | 2055-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,25% | 127 K | 86,34% | 4,250% | 2049-11-21 | 5,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,25% | 19 K | 95,03% | 4,875% | 2048-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,24% | 125 K | 102,37% | 5,400% | 2054-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,23% | 0 | 90,25% | 4,450% | 2046-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,23% | 45 K | 94,21% | 4,750% | 2045-03-15 | 827,09 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,22% | 0 | 93,68% | 4,700% | 2045-05-14 | 2,7 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,19% | 1 M | 95,95% | 4,850% | 2044-06-15 | 1,01 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,16% | 100 K | 102,25% | 5,350% | 2044-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,10% | 70 K | 92,02% | 4,400% | 2042-11-06 | 2,6 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,07% | 50 K | 94,93% | 4,625% | 2042-10-01 | 389,22 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,93% | 495 K | 91,07% | 4,050% | 2039-11-21 | 4 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,65% | 0 | 97,13% | 4,300% | 2036-05-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,59% | 0 | 99,31% | 4,500% | 2035-05-14 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,57% | 35 K | 104,72% | 5,200% | 2035-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,54% | 495 K | 100,07% | 4,550% | 2035-03-15 | 1,68 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,44% | 272 K | 104,21% | 5,050% | 2034-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,10% | 4 K | 104,08% | 4,950% | 2031-03-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,05% | 0 | 99,56% | 3,200% | 2026-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,99% | 6,89 M | 97,06% | 3,200% | 2029-11-21 | 5,44 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,98% | 312 K | 103,58% | 4,875% | 2030-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,92% | 561 K | 100,93% | 4,250% | 2028-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 3,90% | 0 | 94,13% | 2,125% | 2029-06-01 | 36,46 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS |
| 3,89% | 700 K | 102,85% | 4,800% | 2029-03-15 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,89% | 900 K | 101,23% | 4,800% | 2027-03-15 | 2,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,85% | 508 K | 99,06% | 2,950% | 2026-11-21 | 3,99 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,82% | 5,2 M | 101,87% | 4,650% | 2028-03-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,16% | 0 | 126,76% | 4,750% | 2045-03-15 | 5 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,13% | 0 | 128,71% | 4,850% | 2044-06-15 | 100 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,13% | 0 | 121,31% | 4,250% | 2049-11-21 | 4,95 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 2,74% | 0 | 91,76% | 1,250% | 2031-11-18 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| 2,57% | 0 | 123,74% | 4,550% | 2035-03-15 | 1 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 2,56% | 0 | 98,50% | 2,125% | 2029-06-01 | 506,09 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| 2,43% | 0 | 100,56% | 2,625% | 2028-11-15 | 427,79 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| 2,38% | 0 | 99,25% | 2,125% | 2028-11-17 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| 2,24% | 0 | 97,04% | 0,750% | 2027-11-18 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| −5,92% | 0 | 111,17% | 2,950% | 2026-11-21 | 9,24 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| — | — | — | 4,400% | 2042-11-06 | 1,1 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |